Alzheimer’s Society Responds To BMJ Debate: Does Long Term Use Of Psychiatric Drugs Cause More Harm Than Good?

In a debate article to be published in the BMJ on Tuesday 12 May 2015, two scientists argue whether long term use of psychiatric drugs cause more harm than good.

Peter Gotzsche says that psychiatric drugs are responsible for the deaths of more than half a million people aged 65 and older each year in the Western world.

Whilst Allan Young argues that evidence supports the long term use of psychiatric drugs and insists they are rigorously examined for safety before and after regulatory approval.

Dr Doug Brown, Director of Research and Development at Alzheimer’s Society said:

‘In his article, Professor Gotzsche suggests dropping all “dementia drugs”. In 2010, Alzheimer’s Society campaigned hard for NICE to approve drugs such as Aricept for people with Alzheimer’s disease. Since then, these drugs have been shown to provide real benefits for many people living with dementia, providing help with daily living.

‘The use of antipsychotic drugs on the other hand is an outdated way to treat symptoms of dementia like aggression. Although we appreciate these drugs are important for a minority of people with dementia, they can leave people heavily sedated, damage their quality of life and even lead to death and should only be used as a last resort.

‘We welcome a debate on drugs, but we need to ensure that those drugs working well for people with dementia remain available to all who so desperately need them.’







Sign up for all the latest news from The Carer!

Sign up to receive the latest issues, along with highlights of the latest sector news and more from The Carer, delivered directly to your inbox twice a week!